Gut radiation may revive immunotherapy in resistant cancers
Disease control
Completed
This phase 2 trial investigates whether a single, low dose of radiation to the small intestine can help the immune system recognize and attack tumors again in people with advanced solid cancers that have stopped responding to immunotherapy. Participants receive 1Gy of radiation t…
Phase: PHASE2 • Sponsor: Chuangzhen Chen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC